Dr. Sarkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11715 Rangeland Pkwy
Bradenton, FL 34211Phone+1 941-538-0077Fax+1 941-538-0078
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013- National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2012
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 2004 - 2007
University of Calcutta School of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2008 - Present
CA State Medical License 2010 - 2026
FL State Medical License 2022 - 2026
CT State Medical License 2012 - 2015
VA State Medical License 2010 - 2012
MD State Medical License 2010 - 2011- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 59 citationsExenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 DiabetesGayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-03-01 - Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan
Diabetes Care. 2014-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
